Stuttgart - Delayed Quote EUR

Corvus Pharmaceuticals Inc (C17.SG)

Compare
3.7200
+0.0750
+(2.06%)
At close: 9:59:07 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
25,094
23,407
32,565
38,630
43,760
Operating Income
-25,094
-23,407
-32,565
-38,630
-43,760
Net Non Operating Interest Income Expense
1,696
1,584
654
-15
540
Other Income Expense
-33,435
-5,206
-9,396
-4,596
37,225
Pretax Income
-56,833
-27,029
-41,307
-43,241
-5,995
Net Income Common Stockholders
-56,833
-27,029
-41,307
-43,241
-5,995
Diluted NI Available to Com Stockholders
-56,833
-27,029
-41,307
-43,241
-5,995
Basic EPS
-0.99
-0.56
-0.89
-1.03
-0.20
Diluted EPS
-0.99
-0.56
-0.89
-1.03
-0.20
Basic Average Shares
56,147.4070
48,025.2740
46,553.5110
41,854.1100
29,478.8780
Diluted Average Shares
56,147.4070
48,025.2740
46,553.5110
41,854.1100
29,478.8780
Total Operating Income as Reported
-25,094
-23,407
-32,565
-38,630
-43,760
Total Expenses
25,094
23,407
32,565
38,630
43,760
Net Income from Continuing & Discontinued Operation
-56,833
-27,029
-41,307
-43,241
-5,995
Normalized Income
-25,803
-27,029
-41,329
-43,241
-5,995
Interest Income
--
--
--
--
540
Interest Expense
--
--
--
15
--
Net Interest Income
1,696
1,584
654
-15
540
EBIT
-25,094
-23,407
-32,565
-38,630
-43,760
EBITDA
-25,001
-23,256
-32,198
-38,170
-43,128
Reconciled Depreciation
93
151
367
460
632
Net Income from Continuing Operation Net Minority Interest
-56,833
-27,029
-41,307
-43,241
-5,995
Total Unusual Items Excluding Goodwill
-31,030
--
22
--
--
Total Unusual Items
-31,030
--
22
--
--
Normalized EBITDA
6,029
-23,256
-32,220
-38,170
-43,128
12/31/2020 - 4/21/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1VT.SG Viking Therapeutics Inc
24.54
-11.89%
 
W2J.F Carisma Therapeutics, Inc.
0.3716
-1.80%
 
1VT.DU Viking Therapeutics Inc
24.59
-10.39%
 
W2J.SG CARISMA Therapeutics Inc
0.3740
-2.76%
 
0M4.DU Mersana Therapeutics Inc
0.4683
-0.49%
 
0M4.F Mersana Therapeutics, Inc.
0.4229
-0.33%
 
0M4.BE Mersana Therapeutics Inc
0.4663
-1.71%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
7.83
+12.66%
 
0M4.MU Mersana Therapeutics Inc
0.4915
0.00%
 
OBD.L Oxford BioDynamics Plc
0.5150
-6.70%